Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class III · Low risk Terminated Initiated Jun 5, 2014 (12 years ago)

APLENZIN¿ (bupropion hydrobromide)

Class III — Low risk. Unlikely to cause harm, but violates FDA regulations.

Why it was recalled

Labeling: Incorrect or Missing Package Insert

Cause type: Labeling / mix-up

Wrong label, wrong strength, mixed-up products, or packaging errors. One of the most dangerous causes - you can end up taking the wrong drug or the wrong dose. All labeling / mix-up recalls.

What was recalled

APLENZIN¿ (bupropion hydrobromide), extended-release tablets, 174 mg, 7-count HDPE bottle, Rx Only, Manufactured by Valeant Pharmaceuticals International, Inc. Steinbach MB, Canada R5G 1Z7, NDC 0024-5810-07.

Affected NDC 0024-5810-07

Compare with the code on your package — it is the most precise check available.

Drug: Bupropion Category: Mental Health Medication

Recalling firm
Valeant Pharmaceuticals North America LLC
NDC code
0024-5810-07
Origin
NJ, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0051-2015 · FDA notice

Low risk, still worth a check. Class III means the product is unlikely to cause harm but breaks an FDA rule (often labeling). If your lot matches, your pharmacy will normally swap it; there is no need for alarm. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Bupropion recalls

See all

Other recalls by Valeant Pharmaceuticals North America LLC

All 2014 recalls
Class III · Low risk

Diltiazem HCl CD capsules

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 68682-521-01 D-0491-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0798-30 D-0490-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0797-30 D-0489-2019
Class III · Low risk

Cardizem CD

Failed Dissolution Specifications: high out of specification results for dissolution when measuring the amount of drug released at certain time points.

Terminated Dissolution failure Valeant Pharmaceuticals North America LLC NDC 0187-0796-30 D-0488-2019